This document was printed from the website of the California Evidence-Based Clearinghouse for Child Welfare (CEBC), which you can access at http://www.cebc4cw.org/
This document was printed from the website of the California Evidence-Based Clearinghouse for Child Welfare (CEBC), which you can access at http://www.cebc4cw.org/
Note: Arkansas Center for Addictions Research, Education, and Services (AR-CARES) was not responsive to the CEBC's request for information about their program. The following information was obtained from publicly available sources (websites, articles, etc.).
Scientific Rating:
3
Promising Research Evidence
See scale of 1-5
Relevance to Child Welfare Rating:
2
Medium
See scale of 1-3
Child Welfare Outcomes: Well-Being
Brief Description:
Arkansas Center for Addictions Research, Education, and Services (AR-CARES) has been rated by the CEBC in the area of Substance Abuse Treatment (Adult). AR-CARES provides services to mothers with dual diagnosis of substance abuse and mental health problems. Treatment is primarily provided in a long-term residential setting with family support and treatment services based on the Teaching-Family Model. Mothers are referred either when they are pregnant or enter treatment with their children. Additional services include maternal and child health care, parent training, vocational and educational training, and children's mental health and early education services.
Manual and Training section:
The publicly available information indicates that there is some training available for Arkansas Center for Addictions Research, Education, and Services (AR-CARES), please contact Linda. L. M. Worley, MD, University of Arkansas for Medical Sciences, College of Medicine, Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Email: WorleyLindaL@uams.edu.
Relevant Published, Peer-Reviewed Research:
Arkansas Center for Addictions Research, Education, and Services (AR-CARES) was given the scientific rating of "3-Promising Research Evidence" based on the published, peer-reviewed research available. The practice must have at least one study utilizing some form of control (e.g., untreated group, placebo group, matched wait list) establishing the practice's benefit over the placebo, or found it to be comparable to or better than an appropriate comparison practice. For more information, please see the Scientific Rating Scale.
Whiteside-Mansell, L., Crone, C., & Conners, N. (1999). The development and evaluation of an alcohol and drug prevention and treatment program for women and children. Journal of Substance Abuse Treatment, 16(3), 265-275.
Type of Study: Non-randomized comparison group
Number of participants: 95
Population:
Location/Institution: Arkansas
Summary: (To include comparison groups, outcomes, measures, notable limitations): The study compared women and children participating in the CARES program with those who had refused service. Women's reported drug use was assessed at intake and between intake and delivery of the target child. Alcohol use in the CARES group dropped from 83.6% at intake to 4% at delivery. Use in the non-participating group dropped from 90.5% to 33%. Similar levels were reported for other types of drug use. The study also examined birth outcomes. Fewer participating women experience premature labor or maternal infection and their hospital stays were shorter. Longer program participation was associated with higher birth weight. This study could not compare child developmental outcomes across groups, but all children in the participating group score in normal health ranges at 12 and 18 months, as assessed by Bayley Scales of Infant Development. Limitations include lack of random assignment and lack of comparison data for children's follow-up.
Length of post-intervention follow-up: 18 months after delivery of target child.
Conners, N. A., Bradley, R. H., Whiteside-Mansell, L., & Crone, C. C. (2001). A comprehensive substance abuse treatment program for women and their children: an initial evaluation. Journal of Substance Abuse Treatment, 21, 67-75.
Type of Study: Non-randomized comparison groups
Number of participants: 72
Population:
Age Range: 16 to 44
Race/Ethnicity: Majority African American in all groups. Caucasian: 42.9% late dropout group, 21.4% early dropout group, 13.3% graduate group.
Status (e.g., foster care, CW): Participants in residential substance abuse treatment for women with children.
Location/Institution: Arkansas
Summary: (To include comparison groups, outcomes, measures, notable limitations) This study compares outcomes for women and children across three treatment groups: clients who stayed in treatment less than 30 days (early drop-out), those who stayed in more than 30 days but did not complete treatment (late drop-out), and those who completed the program (graduates). Assessments were taken at baseline, every three months after intake, and at 3, 6, and 12 months after discharge. Mothers were assessed with the Addiction Severity Index, the Parenting Stress Index, the Outcomes of Addiction Questionnaire, and the Family Cohesiveness Scale. Children were assessed with the Scales of Independent Behavior-Revised (SIB-R) and the Denver Developmental Screening Test. The authors also administered a scale designed for this project to measure ability to resist using drugs. Analysis showed that 15% of the graduate group experienced a relapse during follow-up, compared to 50% of early drop-outs and 61% of late dropouts. The groups did not differ on number of days of substance use. There were no group differences in self-reported negative consequences of substance use. In addition, few graduates had poverty level incomes or arrests. They also improved more on parenting stress scores and family cohesion. No significant group differences were found in children's behavior or drug resistance skills scores. Study limitations include very small group sizes, lack of randomized design and lack of an untreated comparison group.
Length of post-intervention follow-up: 12 months after discharge
References:
Worley, L. L. M., Conners, N. A., Crone, C. C., Williams, V. L., & Bokony, P. A. (2005). Building a residential treatment program for dually diagnosed women with their children. Archives of Women's Mental Health, 8, 105-111.
Contact Information
Name: Dr. Rita Galloway, Executive Director
Affiliation/Agency: Arkansas Cares
E-mail: rgalloway@methodistfamily.org
Website: www.methodistfamily.org/programs/arkansas-CARES.html
Date review compiled: June 2009